Hypertension

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC4-11

DiraChart Clinical Reference
Protected section 11 of 14
← Document menu
Home Care · DiraChart

1. Where this overlay applies

DiraChart Clinical Reference

Section NavigationPart 11 of 14PreviousNext

At goal / managed

G1

Controlled HTN, home log reviewed

Hypertension-specific review completed alongside the vital-signs examination. Blood pressure 132/78 left arm, seated with appropriate cuff size after a 5-minute rest, within the ordered range; repeat 130/76; heart rate 68. The patient denies headache, visual change, chest pain, dyspnea, or dizziness. The home blood-pressure log was reviewed: readings consistent, no missed entries, average within parameters, and technique observed and correct. Findings stable from the prior visit. RN-level assessment was required to verify measurement technique and medication adherence and to screen for symptoms of severe elevation and treatment-related hypotension. Provider thresholds and missed-dose instructions reinforced; teach-back accurate. Continued skilled monitoring indicated.

G2

HTN with orthostatic awareness, no symptomatic drop

Hypertension-specific review completed. Seated blood pressure 134/80, heart rate 72; standing 128/78, heart rate 80 at one minute with no symptoms and no orthostatic drop meeting threshold today (orthostatics performed in the parent module). The patient denies dizziness, near-falls, or visual change and reports steady ambulation with the walker. Findings stable. RN-level assessment was required to evaluate for treatment-related orthostatic hypotension given the antihypertensive and diuretic regimen and the associated fall risk. Slow position changes, hydration within fluid orders, and fall-prevention measures reinforced; teach-back accurate. Continued skilled monitoring indicated.

G3

Stable after regimen titration, electrolytes monitored

Hypertension-specific review completed after a recent antihypertensive titration. Blood pressure within the ordered range with correct technique; heart rate within range; the patient denies dizziness, headache, or new adverse effects. The ordered basic metabolic panel was reviewed and potassium and renal function are within parameters. Findings indicate a stable response to the titrated regimen. RN-level assessment was required to evaluate the titration response and screen for electrolyte and renal effects. Adherence, the report thresholds, and adverse-effect recognition reinforced; continued skilled monitoring indicated.

G4

White-coat pattern clarified by home log, at goal

Hypertension-specific review completed. In-home blood pressure measured at 142/86 on arrival but 130/78 after rest with correct technique; the home log shows consistent readings within the ordered range and supports good control, clarifying an office-elevated (white-coat) pattern. The patient denies symptoms. Findings are at goal by home monitoring. RN-level assessment was required to reconcile in-office and home readings, verify technique, and prevent over-treatment. Correct measurement timing and conditions and continued logging reinforced; teach-back accurate. Continued skilled monitoring indicated.

Section NavigationPart 11 of 14PreviousNext